NewsBenzingaGoldman Sachs behält die Einstufung „Neutral“ für Moderna bei und hebt das Kursziel auf 137 US-Dollar an Goldman Sachs behält die Einstufung „Neutral“ für Moderna bei und hebt das Kursziel auf 137 US-Dollar an Benzinga 2026.10.15 11:23 (GMT+0) Open on Benzinga Other news Meta Platforms Earnings Preview: What to Expect ‘I Watch Something on YouTube Every Day’ but Netflix a ‘Dormant Subscription,’ Says Chamath Palihapitiya Underlining a Financial Lesson SpaceX to attempt first simultaneous recovery of Starship and booster next month Global Mofy AI Shares Sink 14% After Hours: Here's Why Elon Musk Says Social Media Can Feel Dark Sometimes, Here’s the Other Place Billionaire Gets News HSBC: Liquidity depth will determine whether Ripple's 24/7 derivatives service can attract more institutions
‘I Watch Something on YouTube Every Day’ but Netflix a ‘Dormant Subscription,’ Says Chamath Palihapitiya Underlining a Financial Lesson
HSBC: Liquidity depth will determine whether Ripple's 24/7 derivatives service can attract more institutions
